Traded Nov 21, 2025 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Traded Oct 27, 2025 · Filed Oct 28, 2025
A Bridgewater Bancshares director paid $235K out of pocket for Bridgewater Bancshares shares. The Bridgewater Bancshares shares held grew by 79%.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$235,194
Shares × reported transaction price
$100K–$500K
+78.7%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 1 earlier confirmed purchase
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
6 days after results of Oct 21, 2025, 92 days before results of Jan 27, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded Nov 21, 2025 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Traded Nov 21, 2025 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Traded Nov 21, 2025 · filed 3 days laterNot under a reported trading plan
Bridgewater Bancshares's & CHIEF STRATEGY OFFICER sold $101K of Bridgewater Bancshares shares. The filing does not indicate a pre-arranged trading plan.